Read More

Billions On The Move: Tracking Market Cap Changes In Top Cannabis Firms After DEA Rescheduling Announcement

Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injected billions into the publicly traded market for cannabis companies.

ACB

Read More

Cannabis Companies’ Gains U.S. Versus Canada: Averages Can Be Deceiving, Irrational Market Behavior To Blame?

Recent insights from Viridian Capital Advisors shed light on the bewildering trends in cannabis stocks. Year-to-date (YTD) data indicates that U.S. multi-state operators (MSOs) and Canadian licensed producers (LPs) have experienced drastically different fates. At a glance, U.S. MSOs show an average return of 26.4%, towering over Canadian LPs' modest 1.3%.

TCNNF